fullerene c60 has been researched along with Experimental Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Du, B; Han, S; Li, H; Su, X; Zhang, Z; Zhao, F | 1 |
| Berger, W; Chumakl, VV; Evstigneev, MP; Heffeter, P; Lehka, LV; Panchuk, RR; Prylutska, SV; Prylutskyy, YI; Ritter, U; Scharff, P; Skorokhyd, NR; Stoika, RS | 1 |
| Cui, R; Dong, J; Guo, X; Huang, H; Li, C; Li, J; Li, Y; Liu, B; Liu, S; Sun, B; Xing, G; Xu, B; Yao, H | 1 |
| Chang, Y; Chen, K; He, R; Jin, J; Li, J; Song, Y; Sun, B; Wang, Y; Xing, G; Zhang, M | 1 |
| Chen, D; Chu, T; Ge, J; Guan, M; Hao, X; Shu, C; Wang, C; Wu, J; Zhang, G; Zhang, W; Zhang, Y; Zhen, M; Zou, T | 1 |
| Cai, T; Chen, ZJ; Corwin, FD; Dorn, HC; Fatouros, PP; Gibson, HW; Long, GL; Owens, LS; Reid, J; Shu, C; Zhang, J | 1 |
| Chai, Z; Chen, C; Chen, Z; Fang, X; Gao, Y; Jia, G; Li, B; Meng, H; Sun, J; Tang, J; Wang, J; Wang, T; Xing, G; Xing, L; Yuan, H; Zhao, F; Zhao, Y | 1 |
7 other study(ies) available for fullerene c60 and Experimental Neoplasms
| Article | Year |
|---|---|
Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.
Topics: Animals; Antineoplastic Agents; Cell Survival; Contrast Media; Delayed-Action Preparations; Diffusion; Docetaxel; Female; Fullerenes; Liposomes; Magnetic Resonance Imaging; Magnetite Nanoparticles; MCF-7 Cells; Mice; Mice, Inbred C57BL; Nanocomposites; Neoplasms, Experimental; Photochemotherapy; Radio Waves; Taxoids; Theranostic Nanomedicine | 2015 |
Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Doxorubicin; Fullerenes; HL-60 Cells; Humans; Male; MCF-7 Cells; Mice; Mice, Inbred C57BL; Nanoconjugates; Neoplasms, Experimental; Particle Size; Treatment Outcome | 2015 |
Fluorescent activatable gadofullerene nanoprobes as NIR-MR dual-modal in vivo imaging contrast agent.
Topics: Animals; Contrast Media; Female; Fluorescent Dyes; Fullerenes; HeLa Cells; Humans; Infrared Rays; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Optical Imaging; Spectrometry, Fluorescence; Uterine Cervical Neoplasms | 2018 |
Gd@C82(OH)22 nanoparticles constrain macrophages migration into tumor tissue to prevent metastasis.
Topics: Animals; Cell Communication; Cell Line; Cell Movement; Cell Size; Fullerenes; Gadolinium; Macrophages; Mice; Nanoparticles; Neoplasms, Experimental; Tumor Microenvironment | 2014 |
Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy.
Topics: A549 Cells; Absorption, Physicochemical; Animals; Apoptosis; Chlorophyllides; Diffusion; Female; Fullerenes; Humans; Mice; Mice, Inbred BALB C; Nanocapsules; Neoplasms, Experimental; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tissue Distribution; Treatment Outcome | 2016 |
High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.
Topics: Animals; Brain Neoplasms; Contrast Media; Disease Models, Animal; Fullerenes; Gadolinium; Magnetic Resonance Imaging; Models, Molecular; Molecular Weight; Neoplasms, Experimental; Nitrogen; Organometallic Compounds; Particle Size; Polyethylene Glycols; Rats; Tissue Distribution | 2010 |
Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity.
Topics: Animals; Antineoplastic Agents; Cadmium Compounds; Female; Fullerenes; Immune System; Mice; Mice, Inbred Strains; Nanoparticles; Neoplasm Transplantation; Neoplasms, Experimental | 2005 |